Items in AFP with MESH term: Diabetes Mellitus, Type 2

Pages: Previous 1 2 3 4 5 6 Next

Angiotensin Blockade in Patients with Diabetic Nephropathy - FPIN's Clinical Inquiries


Alpha-glucosidase Inhibitors May Reduce the Risk of Type 2 Diabetes - Cochrane for Clinicians


Preventing Diabetes in Youth: Lessons from Smoking-Cessation Efforts - Editorials


Risk-Assessment Tools for Detecting Undiagnosed Diabetes - Point-of-Care Guides


Type 2 Diabetes: Separating Proven from Unproven Interventions - Editorials


Low Glycemic Index Diets for the Management of Diabetes - Cochrane for Clinicians


Screening for Type 2 Diabetes Mellitus in Adults: Recommendation Statement - U.S. Preventive Services Task Force


Screening for Asymptomatic Bacteriuria in Adults - Putting Prevention into Practice


Diabetes Mellitus: Diagnosis and Screening - Article

ABSTRACT: Based on etiology, diabetes is classified as type 1 diabetes mellitus, type 2 diabetes mellitus, latent autoimmune diabetes, maturity-onset diabetes of youth, and miscellaneous causes. The diagnosis is based on measurement of A1C level, fasting or random blood glucose level, or oral glucose tolerance testing. Although there are conflicting guidelines, most agree that patients with hypertension or hyperlipidemia should be screened for diabetes. Diabetes risk calculators have a high negative predictive value and help define patients who are unlikely to have diabetes. Tests that may help establish the type of diabetes or the continued need for insulin include those reflective of beta cell function, such as C peptide levels, and markers of immune-mediated beta cell destruction (e.g., autoantibodies to islet cells, insulin, glutamic acid decarboxylase, tyrosine phosphatase [IA-2a and IA-2ß]). Antibody testing is limited by availability, cost, and predictive value.


Latent Autoimmune Diabetes in Adults - Editorials


Pages: Previous 1 2 3 4 5 6 Next


Information From Industry